BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36424904)

  • 1. Spontaneous preterm birth risk among HPV-vaccinated and -unvaccinated women: a nationwide retrospective cohort study of over 240 000 singleton births.
    McClymont E; Faber MT; Belmonte F; Kjaer SK
    BJOG; 2023 Mar; 130(4):358-365. PubMed ID: 36424904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in stillbirths and preterm birth in COVID-19-vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes.
    Hui L; Marzan MB; Rolnik DL; Potenza S; Pritchard N; Said JM; Palmer KR; Whitehead CL; Sheehan PM; Ford J; Mol BW; Walker SP
    Am J Obstet Gynecol; 2023 May; 228(5):585.e1-585.e16. PubMed ID: 36336084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trial.
    Kalliala I; Eriksson T; Aro K; Hokkanen M; Lehtinen M; Gissler M; Nieminen P
    Prev Med; 2021 May; 146():106473. PubMed ID: 33639181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
    Krog L; Lycke KD; Kahlert J; Randrup TH; Jensen PT; Rositch AF; Hammer A
    Am J Obstet Gynecol; 2024 Apr; 230(4):430.e1-430.e11. PubMed ID: 38569830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world effectiveness of HPV vaccination against cervical neoplasia among birth cohorts ineligible for routine vaccination.
    Dong L; Nygård M; Støer NC; Klungsøyr O; Hansen BT
    Int J Cancer; 2023 Jul; 153(2):399-406. PubMed ID: 36866965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women.
    Baldur-Felskov B; Dehlendorff C; Munk C; Kjaer SK
    J Natl Cancer Inst; 2014 Mar; 106(3):djt460. PubMed ID: 24552678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    Osmani V; Fett S; Tauscher M; Donnachie E; Schneider A; Klug SJ
    BMC Cancer; 2022 Dec; 22(1):1293. PubMed ID: 36494790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    Kjaer SK; Dehlendorff C; Belmonte F; Baandrup L
    J Natl Cancer Inst; 2021 Oct; 113(10):1329-1335. PubMed ID: 33876216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    BMC Public Health; 2016 Aug; 15():708. PubMed ID: 27488178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Human Papillomavirus Infection Among Pregnant Women and Preterm Birth.
    Niyibizi J; Mayrand MH; Audibert F; Monnier P; Brassard P; Laporte L; Lacaille J; Zahreddine M; Bédard MJ; Girard I; Francoeur D; Carceller AM; Lacroix J; Fraser W; Coutlée F; Trottier H;
    JAMA Netw Open; 2021 Sep; 4(9):e2125308. PubMed ID: 34524433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
    Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
    BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
    Yoon D; Lee JH; Lee H; Shin JY
    BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females.
    Hofstetter AM; Ompad DC; Stockwell MS; Rosenthal SL; Soren K
    JAMA Pediatr; 2016 May; 170(5):445-52. PubMed ID: 26974250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test.
    Del Mistro A; Battagello J; Weis L; Bressan V; Selle V; Ramigni M; Dal Zotto A; Maggiolo A; Gori S; Frayle H; Zappa M; Zorzi M; The Consensus Study Veneto Working Group
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.
    Faber MT; Duun-Henriksen AK; Dehlendorff C; Tatla MK; Munk C; Kjaer SK
    Vaccine; 2019 Jan; 37(2):265-271. PubMed ID: 30503078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Differential Risk of Cervical Cancer in HPV-Vaccinated and -Unvaccinated Women: A Mathematical Modeling Study.
    Naslazi E; Hontelez JAC; Naber SK; van Ballegooijen M; de Kok IMCM
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):912-919. PubMed ID: 33837119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the human papillomavirus (HPV) immunization programme improved obstetric outcomes in spontaneous delivery? An ecological study.
    Xu X; Woolner A; Bhattacharya S; Cotton S; Zhao F; Cruickshank M
    Eur J Obstet Gynecol Reprod Biol; 2021 Jul; 262():221-227. PubMed ID: 34082145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.